focus -WSS

focus

author：hotspot 2025-09-29 13:46:08 - browse：89394

novavax photo illo — JUSTIN TALLIS/AFP via Getty Images

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, all. Damian here with an update on the plight of the other Covid-19 vaccine company, Wall Street’s latest GLP-1 trade, and the quest for a universal antivenom.

The need-to-know this morning

Ocular Therapeutics announced a shakeup of its senior management team and a $325 million private placement.
Amylyx Therapeutics said results from a closely followed Phase 3 study of its treatment for ALS could come before the start of the second quarter — earlier than previously expected.
Moderna earnings are here.

Novavax’s money is going in the wrong direction

The good news for Novavax is that it’s no longer facing a $700 million dispute with a global charity organization. The bad news is that settling that dispute will force the struggling company to pay out $400 million over the next five years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Biotech startup Celsius cuts 75% of staff ahead of first trial start

leisure time

WSS

'Null' research findings aren't empty of meaning. Let's publish them

Colonoscopy at 40? Study finds a possible benefit

Flint parents haunted by uncertainty, fears of lead poisoning

A controversial new treatment promises to make little people taller

Alnylam reports growth in sales of rare disease treatments

A controversial new treatment promises to make little people taller

entertainment

focus

The need-to-know this morning

Novavax’s money is going in the wrong direction

focus

Drug repurposing or repositioning? The language matters

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Medical leaders decry Supreme Court decision on affirmative action

It costs an awful lot of money to give away a kidney

The cancer drug shortage isn’t new — and neither are the solutions

Why we need to separate burnout from moral injury in health care

United colonoscopy coverage change 'may cost lives,' doctors say

STAT's guide to the next generation of CAR

Jerome Adams on the need for new antivirals for Covid

Gene therapy has helped boys walk. Can scientists keep it that way?

focus

Why are elite athletes different? Take a look at their microbes

How to ethically and practically extend health care to all

WATCH: Why do fingernails fall off when they're damaged?

Heart disease in astronauts blamed on cosmic radiation

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Disclosing genetic information: not as worrisome as once feared

knowledge

entertainment

leisure time

explore